APO Research

APO RESEARCH · REPORT

Amrinone for Injection

Selected research

Market Analysis & Forecast

Global Amrinone for Injection Market Analysis and Forecast 2026-2032

Market perspective

The global Amrinone for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Amrinone for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Amrinone for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Amrinone for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Amrinone for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Amrinone for Injection include Qilu Pharmaceutical Co., Ltd., Hainan Huanglong Pharmaceutical Co., Ltd. and Dandong Yichuang Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Amrinone for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Amrinone for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Amrinone for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amrinone for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Amrinone for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Amrinone for Injection sales, projected growth trends, production technology, application and end-user industry.

Amrinone for Injection Segment by Company

Qilu Pharmaceutical Co., Ltd.

Hainan Huanglong Pharmaceutical Co., Ltd.

Dandong Yichuang Pharmaceutical Co., Ltd.

Amrinone for Injection Segment by Type

50mg

100mg

Amrinone for Injection Segment by Application

Hospital

Clinic

Other

Amrinone for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amrinone for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amrinone for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amrinone for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Amrinone for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Amrinone for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amrinone for Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Amrinone for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mg Major Manufacturers Table 3. 100mg Major Manufacturers Table 4. Global Amrinone for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Amrinone for Injection Industry Trends Table 9. Amrinone for Injection Industry Drivers Table 10. Amrinone for Injection Industry Opportunities and Challenges Table 11. Amrinone for Injection Industry Restraints Table 12. Global Amrinone for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Amrinone for Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Amrinone for Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Amrinone for Injection Revenue Market Share by Region (2021-2026) Table 16. Global Amrinone for Injection Revenue Market Share by Region (2027-2032) Table 17. Global Amrinone for Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Amrinone for Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Amrinone for Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Amrinone for Injection Sales Market Share by Region (2021-2026) Table 21. Global Amrinone for Injection Sales Market Share by Region (2027-2032) Table 22. Global Amrinone for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Amrinone for Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Amrinone for Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Amrinone for Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Amrinone for Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Amrinone for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Amrinone for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Amrinone for Injection Manufacturers, Product Type & Application Table 30. Global Amrinone for Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Amrinone for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Amrinone for Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Amrinone for Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Amrinone for Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Amrinone for Injection Revenue Market Share by Type (2021-2026) Table 37. Global Amrinone for Injection Revenue Market Share by Type (2027-2032) Table 38. Global Amrinone for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Amrinone for Injection Sales by Type (2021-2026) & (K Units) Table 40. Global Amrinone for Injection Sales by Type (2027-2032) & (K Units) Table 41. Global Amrinone for Injection Sales Market Share by Type (2021-2026) Table 42. Global Amrinone for Injection Sales Market Share by Type (2027-2032) Table 43. Global Amrinone for Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Amrinone for Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Amrinone for Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Amrinone for Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Amrinone for Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Amrinone for Injection Revenue Market Share by Application (2021-2026) Table 49. Global Amrinone for Injection Revenue Market Share by Application (2027-2032) Table 50. Global Amrinone for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Amrinone for Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Amrinone for Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Amrinone for Injection Sales Market Share by Application (2021-2026) Table 54. Global Amrinone for Injection Sales Market Share by Application (2027-2032) Table 55. Global Amrinone for Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Amrinone for Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Qilu Pharmaceutical Co., Ltd. Company Information Table 58. Qilu Pharmaceutical Co., Ltd. Business Overview Table 59. Qilu Pharmaceutical Co., Ltd. Amrinone for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Qilu Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio Table 61. Qilu Pharmaceutical Co., Ltd. Recent Development Table 62. Hainan Huanglong Pharmaceutical Co., Ltd. Company Information Table 63. Hainan Huanglong Pharmaceutical Co., Ltd. Business Overview Table 64. Hainan Huanglong Pharmaceutical Co., Ltd. Amrinone for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Hainan Huanglong Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio Table 66. Hainan Huanglong Pharmaceutical Co., Ltd. Recent Development Table 67. Dandong Yichuang Pharmaceutical Co., Ltd. Company Information Table 68. Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview Table 69. Dandong Yichuang Pharmaceutical Co., Ltd. Amrinone for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Dandong Yichuang Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio Table 71. Dandong Yichuang Pharmaceutical Co., Ltd. Recent Development Table 72. North America Amrinone for Injection Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Amrinone for Injection Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Amrinone for Injection Sales by Type (2021-2026) & (K Units) Table 75. North America Amrinone for Injection Sales by Type (2027-2032) & (K Units) Table 76. North America Amrinone for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Amrinone for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Amrinone for Injection Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Amrinone for Injection Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Amrinone for Injection Sales by Application (2021-2026) & (K Units) Table 81. North America Amrinone for Injection Sales by Application (2027-2032) & (K Units) Table 82. North America Amrinone for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Amrinone for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Amrinone for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Amrinone for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Amrinone for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Amrinone for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Amrinone for Injection Sales by Country (2021-2026) & (K Units) Table 89. North America Amrinone for Injection Sales by Country (2027-2032) & (K Units) Table 90. North America Amrinone for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Amrinone for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 93. Canada Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 94. Mexico Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 95. Europe Amrinone for Injection Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Amrinone for Injection Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Amrinone for Injection Sales by Type (2021-2026) & (K Units) Table 98. Europe Amrinone for Injection Sales by Type (2027-2032) & (K Units) Table 99. Europe Amrinone for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe Amrinone for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe Amrinone for Injection Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Amrinone for Injection Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Amrinone for Injection Sales by Application (2021-2026) & (K Units) Table 104. Europe Amrinone for Injection Sales by Application (2027-2032) & (K Units) Table 105. Europe Amrinone for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe Amrinone for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe Amrinone for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Amrinone for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Amrinone for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Amrinone for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe Amrinone for Injection Sales by Country (2021-2026) & (K Units) Table 112. Europe Amrinone for Injection Sales by Country (2027-2032) & (K Units) Table 113. Europe Amrinone for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe Amrinone for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 116. France Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 117. U.K. Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 118. Italy Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 119. Russia Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 120. Spain Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 123. Sweden Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 124. Poland Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 125. China Amrinone for Injection Revenue by Type (2021-2026) & (US$ Million) Table 126. China Amrinone for Injection Revenue by Type (2027-2032) & (US$ Million) Table 127. China Amrinone for Injection Sales by Type (2021-2026) & (K Units) Table 128. China Amrinone for Injection Sales by Type (2027-2032) & (K Units) Table 129. China Amrinone for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China Amrinone for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China Amrinone for Injection Revenue by Application (2021-2026) & (US$ Million) Table 132. China Amrinone for Injection Revenue by Application (2027-2032) & (US$ Million) Table 133. China Amrinone for Injection Sales by Application (2021-2026) & (K Units) Table 134. China Amrinone for Injection Sales by Application (2027-2032) & (K Units) Table 135. China Amrinone for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China Amrinone for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Amrinone for Injection Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Amrinone for Injection Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Amrinone for Injection Sales by Type (2021-2026) & (K Units) Table 140. Asia Amrinone for Injection Sales by Type (2027-2032) & (K Units) Table 141. Asia Amrinone for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia Amrinone for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia Amrinone for Injection Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Amrinone for Injection Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Amrinone for Injection Sales by Application (2021-2026) & (K Units) Table 146. Asia Amrinone for Injection Sales by Application (2027-2032) & (K Units) Table 147. Asia Amrinone for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia Amrinone for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Amrinone for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Amrinone for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Amrinone for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Amrinone for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia Amrinone for Injection Sales by Country (2021-2026) & (K Units) Table 154. Asia Amrinone for Injection Sales by Country (2027-2032) & (K Units) Table 155. Asia Amrinone for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia Amrinone for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 158. South Korea Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 159. India Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 160. Australia Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Amrinone for Injection Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Amrinone for Injection Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Amrinone for Injection Sales by Type (2021-2026) & (K Units) Table 166. SAMEA Amrinone for Injection Sales by Type (2027-2032) & (K Units) Table 167. SAMEA Amrinone for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA Amrinone for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA Amrinone for Injection Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Amrinone for Injection Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Amrinone for Injection Sales by Application (2021-2026) & (K Units) Table 172. SAMEA Amrinone for Injection Sales by Application (2027-2032) & (K Units) Table 173. SAMEA Amrinone for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA Amrinone for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA Amrinone for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Amrinone for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Amrinone for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Amrinone for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA Amrinone for Injection Sales by Country (2021-2026) & (K Units) Table 180. SAMEA Amrinone for Injection Sales by Country (2027-2032) & (K Units) Table 181. SAMEA Amrinone for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA Amrinone for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 184. Argentina Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 185. Chile Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 186. Colombia Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 187. Peru Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 189. Israel Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 190. UAE Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 191. Turkey Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 192. Iran Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 193. Egypt Amrinone for Injection Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Amrinone for Injection Distributors List Table 197. Amrinone for Injection Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Amrinone for Injection Image Figure 2. Global Amrinone for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amrinone for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mg Image Figure 5. 100mg Image Figure 6. Global Amrinone for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Amrinone for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Amrinone for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Amrinone for Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Amrinone for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Amrinone for Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Amrinone for Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Amrinone for Injection Sales (2021-2032) & (K Units) Figure 17. Global Amrinone for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Amrinone for Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Amrinone for Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Amrinone for Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Amrinone for Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Amrinone for Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Amrinone for Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Amrinone for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Amrinone for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Amrinone for Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Amrinone for Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Amrinone for Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Amrinone for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Amrinone for Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Amrinone for Injection Sales Market Share by Type (2021-2032) Figure 33. Global Amrinone for Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Amrinone for Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Amrinone for Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Amrinone for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Amrinone for Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Amrinone for Injection Sales Market Share by Application (2021-2032) Figure 39. North America Amrinone for Injection Revenue Share by Type (2021-2032) Figure 40. North America Amrinone for Injection Sales Share by Type (2021-2032) Figure 41. North America Amrinone for Injection Revenue Share by Application (2021-2032) Figure 42. North America Amrinone for Injection Sales Share by Application (2021-2032) Figure 43. North America Amrinone for Injection Revenue Share by Country (2021-2032) Figure 44. North America Amrinone for Injection Sales Share by Country (2021-2032) Figure 45. Europe Amrinone for Injection Revenue Share by Type (2021-2032) Figure 46. Europe Amrinone for Injection Sales Share by Type (2021-2032) Figure 47. Europe Amrinone for Injection Revenue Share by Application (2021-2032) Figure 48. Europe Amrinone for Injection Sales Share by Application (2021-2032) Figure 49. Europe Amrinone for Injection Revenue Share by Country (2021-2032) Figure 50. Europe Amrinone for Injection Sales Share by Country (2021-2032) Figure 51. China Amrinone for Injection Revenue Share by Type (2021-2032) Figure 52. China Amrinone for Injection Sales Share by Type (2021-2032) Figure 53. China Amrinone for Injection Revenue Share by Application (2021-2032) Figure 54. China Amrinone for Injection Sales Share by Application (2021-2032) Figure 55. Asia Amrinone for Injection Revenue Share by Type (2021-2032) Figure 56. Asia Amrinone for Injection Sales Share by Type (2021-2032) Figure 57. Asia Amrinone for Injection Revenue Share by Application (2021-2032) Figure 58. Asia Amrinone for Injection Sales Share by Application (2021-2032) Figure 59. Asia Amrinone for Injection Revenue Share by Country (2021-2032) Figure 60. Asia Amrinone for Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Amrinone for Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Amrinone for Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Amrinone for Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Amrinone for Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Amrinone for Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Amrinone for Injection Sales Share by Country (2021-2032) Figure 67. Amrinone for Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Amrinone for Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Qilu Pharmaceutical Co., Ltd.
  • Hainan Huanglong Pharmaceutical Co., Ltd.
  • Dandong Yichuang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Amrinone for Injection Market by Type
  3. 1.2.1 Global Amrinone for Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mg
  5. 1.2.3 100mg
  6. 1.3 Amrinone for Injection Market by Application
  7. 1.3.1 Global Amrinone for Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Amrinone for Injection Market Dynamics
  1. 2.1 Amrinone for Injection Industry Trends
  2. 2.2 Amrinone for Injection Industry Drivers
  3. 2.3 Amrinone for Injection Industry Opportunities and Challenges
  4. 2.4 Amrinone for Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Amrinone for Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Amrinone for Injection Revenue by Region
  3. 3.2.1 Global Amrinone for Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Amrinone for Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Amrinone for Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Amrinone for Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Amrinone for Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Amrinone for Injection Sales by Region
  9. 3.4.1 Global Amrinone for Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Amrinone for Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Amrinone for Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Amrinone for Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Amrinone for Injection Revenue by Manufacturers
  2. 4.1.1 Global Amrinone for Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Amrinone for Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Amrinone for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Amrinone for Injection Sales by Manufacturers
  6. 4.2.1 Global Amrinone for Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Amrinone for Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Amrinone for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Amrinone for Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Amrinone for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Amrinone for Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Amrinone for Injection Manufacturers, Product Type & Application
  13. 4.7 Global Amrinone for Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Amrinone for Injection Market CR5 and HHI
  16. 4.8.2 2025 Amrinone for Injection Tier 1, Tier 2, and Tier 3
5 Amrinone for Injection Market by Type
  1. 5.1 Global Amrinone for Injection Revenue by Type
  2. 5.1.1 Global Amrinone for Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Amrinone for Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Amrinone for Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Amrinone for Injection Sales by Type
  6. 5.2.1 Global Amrinone for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Amrinone for Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Amrinone for Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Amrinone for Injection Price by Type
6 Amrinone for Injection Market by Application
  1. 6.1 Global Amrinone for Injection Revenue by Application
  2. 6.1.1 Global Amrinone for Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Amrinone for Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Amrinone for Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Amrinone for Injection Sales by Application
  6. 6.2.1 Global Amrinone for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Amrinone for Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Amrinone for Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Amrinone for Injection Price by Application
7 Company Profiles
  1. 7.1 Qilu Pharmaceutical Co., Ltd.
  2. 7.1.1 Qilu Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Qilu Pharmaceutical Co., Ltd. Amrinone for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Qilu Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio
  6. 7.1.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Hainan Huanglong Pharmaceutical Co., Ltd.
  8. 7.2.1 Hainan Huanglong Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Hainan Huanglong Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Hainan Huanglong Pharmaceutical Co., Ltd. Amrinone for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hainan Huanglong Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio
  12. 7.2.5 Hainan Huanglong Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Dandong Yichuang Pharmaceutical Co., Ltd.
  14. 7.3.1 Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Dandong Yichuang Pharmaceutical Co., Ltd. Amrinone for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Dandong Yichuang Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio
  18. 7.3.5 Dandong Yichuang Pharmaceutical Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Amrinone for Injection Market Size by Type
  2. 8.1.1 North America Amrinone for Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Amrinone for Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Amrinone for Injection Price by Type (2021-2032)
  5. 8.2 North America Amrinone for Injection Market Size by Application
  6. 8.2.1 North America Amrinone for Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Amrinone for Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Amrinone for Injection Price by Application (2021-2032)
  9. 8.3 North America Amrinone for Injection Market Size by Country
  10. 8.3.1 North America Amrinone for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Amrinone for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Amrinone for Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Amrinone for Injection Market Size by Type
  2. 9.1.1 Europe Amrinone for Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Amrinone for Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Amrinone for Injection Price by Type (2021-2032)
  5. 9.2 Europe Amrinone for Injection Market Size by Application
  6. 9.2.1 Europe Amrinone for Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Amrinone for Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Amrinone for Injection Price by Application (2021-2032)
  9. 9.3 Europe Amrinone for Injection Market Size by Country
  10. 9.3.1 Europe Amrinone for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Amrinone for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Amrinone for Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Amrinone for Injection Market Size by Type
  2. 10.1.1 China Amrinone for Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Amrinone for Injection Sales by Type (2021-2032)
  4. 10.1.3 China Amrinone for Injection Price by Type (2021-2032)
  5. 10.2 China Amrinone for Injection Market Size by Application
  6. 10.2.1 China Amrinone for Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Amrinone for Injection Sales by Application (2021-2032)
  8. 10.2.3 China Amrinone for Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Amrinone for Injection Market Size by Type
  2. 11.1.1 Asia Amrinone for Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Amrinone for Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Amrinone for Injection Price by Type (2021-2032)
  5. 11.2 Asia Amrinone for Injection Market Size by Application
  6. 11.2.1 Asia Amrinone for Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Amrinone for Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Amrinone for Injection Price by Application (2021-2032)
  9. 11.3 Asia Amrinone for Injection Market Size by Country
  10. 11.3.1 Asia Amrinone for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Amrinone for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Amrinone for Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Amrinone for Injection Market Size by Type
  2. 12.1.1 SAMEA Amrinone for Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Amrinone for Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Amrinone for Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Amrinone for Injection Market Size by Application
  6. 12.2.1 SAMEA Amrinone for Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Amrinone for Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Amrinone for Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Amrinone for Injection Market Size by Country
  10. 12.3.1 SAMEA Amrinone for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Amrinone for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Amrinone for Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Amrinone for Injection Value Chain Analysis
  2. 13.1.1 Amrinone for Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Amrinone for Injection Production Mode & Process
  6. 13.2 Amrinone for Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Amrinone for Injection Distributors
  9. 13.2.3 Amrinone for Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research